These data provide important genetic verification of a recent study showing that healthy lean individuals carrying variants in the insulin response element of the APOC3 gene, leading to increased APOC3 concentrations in plasma, are predisposed to developing NAFLD associated with insulin resistance.9 The gene discussed is APOC3; the disease is metabolic dysfunction-associated steatotic liver disease.